Luwad, Nora Ina S.

HRN: 15-83-89  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2025
CEFUROXIME 750MG (VIAL)
10/18/2025
10/25/2025
IV
750mg
Q8
CAPMR
Waiting Final Action 

Indication:  Empirical De-escalation    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: